![](/img/cover-not-exists.png)
First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability and survival
Pika, Tomas, Hegenbart, Ute, Flodrova, Pavla, Maier, Bettina, Kimmich, Christoph, Schönland, Stefan O.Language:
english
Journal:
Blood
DOI:
10.1182/blood-2017-09-806463
Date:
November, 2017
File:
PDF, 144 KB
english, 2017